The Effects of Agility Ladders on Performance: A Systematic Review.


Journal

International journal of sports medicine
ISSN: 1439-3964
Titre abrégé: Int J Sports Med
Pays: Germany
ID NLM: 8008349

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 13 5 2020
medline: 22 10 2020
entrez: 13 5 2020
Statut: ppublish

Résumé

The goal of this systematic review was to evaluate the effects of exercise programs using agility ladders and to assess the quality of available evidence. Search was conducted in October of 2019 using the following databases: Cochrane Library, PEDro, PubMed, Scopus and Web of Science. Study eligibility criteria included randomized trials or randomized controlled trials using agility ladders drills. Participants were healthy humans of any health status. The study appraisal and synthesis methods followed the revised Cochrane risk-of-bias tool for randomized trials (RoB 2) and a qualitative synthesis of the main results of each study were applied. Only five studies met our criteria, lasting between 4 and 8 weeks. Only two studies evaluated the effects of ladder drills on more than one dimension. Lack of description of the specific exercises that were used limits reproducibility of current studies. With one exception, the articles had low risk of bias for most domains. Despite the widespread popularity of agility ladder drills, research is scarce and problematic, with poorly described protocols and mostly unidimensional performance measures. Claims that agility ladders improve agility and other physical skills is premature, given the nature and quality of existing research.

Identifiants

pubmed: 32396965
doi: 10.1055/a-1157-9078
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

720-728

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest relevant to the content of this review.

Auteurs

José Afonso (J)

Centre for Research, Education, Innovation and Intervention in Sport, University of Porto, Porto, Portugal.

Israel Teoldo da Costa (IT)

NUPEF, NUPEF - Núcleo de Pesquisa e Estudos em Futebol, Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil.

Miguel Camões (M)

Escola Superior de Desporto e Lazer, Instituto Politécnico de Viana do Castelo, Viana do Castelo, Portugal.
The Research Centre in Sports Sciences, Health Sciences and Human Development (CIDESD), Vila Real 5001-801, Portugal.

Ana Silva (A)

Escola Superior de Desporto e Lazer, Instituto Politécnico de Viana do Castelo, Viana do Castelo, Portugal.
The Research Centre in Sports Sciences, Health Sciences and Human Development (CIDESD), Vila Real 5001-801, Portugal.
N2i, Polytechnic Institute of Maia, 4475-690 Maia, Portugal.

Ricardo Franco Lima (RF)

Escola Superior de Desporto e Lazer, Instituto Politécnico de Viana do Castelo, Viana do Castelo, Portugal.
The Research Centre in Sports Sciences, Health Sciences and Human Development (CIDESD), Vila Real 5001-801, Portugal.

André Milheiro (A)

CIFI2D, Centre for Research, Education, Innovation and Intervention in Sport (CIFI2D), Faculty of Sport of the University of Porto (FADEUP), Porto, Portugal.

Alexandre Martins (A)

CIFI2D, Centre for Research, Education, Innovation and Intervention in Sport (CIFI2D), Faculty of Sport of the University of Porto (FADEUP), Porto, Portugal.

Lorenzo Laporta (L)

Universidade Regional Integrada do Alto Uruguai e das missões (Santiago/Brasil).

Fábio Yuzo Nakamura (FY)

Departamento de Educação Física, Universidade Estadual de Londrina, Londrina, Brazil.

Filipe Manuel Clemente (FM)

Escola Superior de Desporto e Lazer, Instituto Politécnico de Viana do Castelo, Viana do Castelo, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH